Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04127110 |
Title | Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients (ALKALINE) |
Acronym | ALKALINE |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | Yes |
Sponsors | European Organisation for Research and Treatment of Cancer - EORTC |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | NLD | GBR | FRA | ESP | BEL |